¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"microbiologic study"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
microbiologic marker
¹Ì»ý¹°Ç¥ÁöÀÚ
air study
°ø±âÁÖÀÔ°Ë»ç
cohort study
ÄÚȣƮ¿¬±¸, ÄÚȣƮÁ¶»ç
controlled clinical study
°ü¸®ÈÀÓ»ó½ÃÇè
crossover study
±³Â÷¿¬±¸
cross-sectional study
´Ü¸é¿¬±¸
case comparison study
ȯÀÚ´ëÁ¶±º¿¬±¸
case referent study
ȯÀÚ´ëÁ¶±º¿¬±¸
case study
Áõ·Ê¿¬±¸, »ç·ÊÁ¶»ç
case-control study
ȯÀÚ´ëÁ¶±º¿¬±¸, »ç·Ê´ëÁ¶±º¿¬±¸
diachronic study
ºñµ¿½Ã¿¬±¸
double blind study
ÀÌÁ߸Ͱ˿¬±¸
ecological study
»ýÅ¿¬±¸
feasibility study
°¡´É¼º¿¬±¸
follow-up study
ÃßÀûÁ¶»ç
´ÙÀ½
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
study design
¿¬±¸¼³°è
study
¿¬±¸, °Ë»ç, Á¶»ç
arterial blood gas study
µ¿¸ÆÇ÷°¡½ººÐ¼®
case-control study
ȯÀÚ´ëÁ¶±º¿¬±¸
cohort study
ÄÚȣƮ¿¬±¸
cross-sectional study
´Ü¸éÁ¶»ç¿¬±¸
ecological study
»ýÅ¿¬±¸
longitudinal study
ÃßÀû¿¬±¸
observational study
°üÂû¿¬±¸
pilot study
¿¹ºñ¿¬±¸
population study
Àα¸Á¶»ç
prospective study
ÀüÇ⿬±¸, °èȹ¿¬±¸, ¾Õ¹æÇ⿬±¸, Àü¸Á¿¬±¸
prospective cohort study
ÀüÇâÄÚȣƮ¿¬±¸
retrospective study
ÈÄÇ⿬±¸, µÞ¹æÇ⿬±¸, ȸ°í¿¬±¸
retrospective cohort study
ÈÄÇâÄÚȣƮ¿¬±¸
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
1
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
microbiologic study
¹Ì»ý¹°Çа˻ç
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
microbiologic marker
¹Ì»ý¹°ÇÐÀûÇ¥ÁöÀÚ
air study
°ø±âÁÖÀÔ°Ë»ç
arterial blood gas study
µ¿¸ÆÇ÷°¡½ººÐ¼®
cardiac gated MR study
½ÉÀ嵿±âÀÚ±â°ø¸í°Ë»ç
case study
Áõ·Ê¿¬±¸
case comparison study
ȯÀÚ´ëÁ¶±º¿¬±¸
case compeer study
ȯÀÚ´ëÁ¶±º¿¬±¸
case referent study
ȯÀÚ´ëÁ¶±º¿¬±¸
case-base study
ȯÀÚ¸ðÁý´Ü¿¬±¸
case-control study
(¢¡retrospective) ÈÄÇ⿬±¸, µÞ¹æÇ⿬±¸
cohort study
(¢¡prospective) °èȹ¿¬±¸, ÀüÇ⿬±¸, ¾Õ¹æÇ⿬±¸
controlled clinical study
°ü¸®ÈÀÓ»ó½ÃÇè
cross-sectional study
´Ü¸éÁ¶»ç¿¬±¸
double-blind study
ÀÌÁ߸Ͱ˹ý
study design
¿¬±¸°èȹ
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
12
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
B cell study
B ¼¼Æ÷°Ë»ç
air study
°ø±â(ÁÖÀÔ) °Ë»ç(¹ý)
arterial blood gas study
µ¿¸ÆÇ÷ °¡½ººÐ¼®
infection control study
°¨¿°°ü¸®¿¬±¸
phase 1 study
ÀÓ»óÁ¦1»ó½ÃÇè.
pilot study
¿¹ºñ½ÇÇè.
population study
Àα¸Á¶»ç
preclinical study
ÀüÀÓ»ó½ÃÇè(îñìúßÉãËúÐ).
pressure flow study
¾Ð·ù·® Á¶»ç
pressure-perfusion study
¾Ð·Â°ü·ù°Ë»ç
prospective study
°èȹÀû¿¬±¸, ÀüÇâÀû¿¬±¸
real time study
½Ç½Ã°£ °Ë»ç
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
1
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
microbiologic study
¹Ì»ý¹°ÇÐÀû °Ë»ç
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
microbiologic marker
¹Ì»ý¹°ÇÐÀû Ç¥ÁöÀÚ
air study
°ø±â(ÁÖÀÔ) °Ë»ç(¹ý)
arterial blood gas study
µ¿¸ÆÇ÷ °¡½ººÐ¼®
cardiac gated MR study
½ÉÀ嵿±â ÀÚ±â°ø¸í °Ë»ç
case control study
ȯÀÚ´ëÁ¶¿¬±¸.
case study
Áõ·Ê¿¬±¸(Áõ¿¹¿¬±¸).
case study
Áõ·Ê¿¬±¸(ñøçÓæÚϼ).
cohort study
ÄÚ¿ÀÆ®¿¬±¸(ÊÙËçË´), Æø·ÎºñÆø·Î¿¬±¸.
controlled clinical study
(Ãß°èÇÐÀû) °ü¸®È(̧ËÌ°ËøË´ËöÌ´)(ÀÓ»ó)½ÃÇè( ËöË×ËàÌ´).
double-blind study
ÀÌÁ߸ͰË.
family study
°¡Á·Á¶»ç(¿¬±¸)
first pass study
ÀÏÂ÷Åë°ú°Ë»ç.
follow-up study
ÃßÀûÁ¶»ç
infection control study
°¨¿°°ü¸®¿¬±¸
molecular genetic study
ºÐÀÚÀ¯ÀüÇÐ<ÀÚ>°Ë»ç
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
ÅëÇÕ°Ë»ö ¿Ï·á
´ÙÀ½